Tigermed Forms Strategic Partnerships With Leading CROs in Russia and S...(will now be able to provide completeregu...),Health

Industry insiders expect the union between leading CROs to facilitate Tigermed's expansion into the various markets and establish its reputation internationally in clinical research and product development. OCT and LSK plan to establish an international customer base through Tigermed's established profile and capabilities in developing new pharmaceutical products.

In addition its clinical research capabilities, TigerMed is recognized in the industry as a specialist for innovative Drug Services. Initial medical discoveries have been carried forward by Tigermed to the path of product development, which turns ideas into realities.

"By forming these strategic alliances, Tigermed takes the pioneering position in exploring business potential and achieving breakthroughs in global service capabilities through cross-border cooperation, which is a significant move for China's CROs. Strategic collaboration is one of our important tactics to expand global business, and this type of partnering becomes an essential part of our international strategy," comments Ms Cao Xiaochun, Vice President of Tigermed, who looks forward to establishing Tigermed as the leading CRO in Asia Pacific within three years, "Tigermed nurtures talent; and strategic partnering will allow great strides forward in the globalization of our talents, which will in the long run, fulfill the ambitions of Tigermed. Tigermed values human capital and seeks to develop this resource globally."

    For more information, please contact:

     Zeng Haiyan
     Tel:   +86-571-8998-6792
     Email: pr@tigermed.net